Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Barletta

Showing results (11-20 of 145) with videos related to

Pageof 15
Sort By:
Pharmacoeconomics|November 26, 2013
Use of proton pump inhibitors for the provision of stress ulcer prophylaxis: clinical and economic consequencesJeffrey F Barletta, David A Sclar
Critical Care (London, England)|February 24, 2021
Drug dosing in the critically ill obese patient: a focus on medications for hemodynamic support and prophylaxisBrian L Erstad, Jeffrey F Barletta
The Journal of Emergency Medicine|July 29, 2022
Dosing Medications for Coagulopathy Reversal in Patients with Extreme ObesityJeffrey F Barletta, Brian L Erstad
The Annals of Pharmacotherapy|October 19, 2022
Dilemmas Related to Direct-Acting Oral Anticoagulant Administration in Patients With Extreme ObesityBrian L Erstad, Jeffrey F Barletta
World Journal of Surgery|April 1, 2014
Reducing the burden of postoperative ileus: evaluating and implementing an evidence-based strategyJeffrey F Barletta, Anthony J Senagore
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 29, 2022
Pharmacologic venous thromboembolism prophylaxis in obese trauma patientsBrian L Erstad, Jeffrey F Barletta
Journal of Critical Care|July 1, 2022
Pitfalls and pearls with drug dosing in the critically ill obese patient: 10 statements to guide ICU practitionersJeffrey F Barletta, Brian L Erstad
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 11, 2005
Albumin for fluid resuscitation: implications of the Saline versus Albumin Fluid EvaluationJohn W Devlin, Jeffrey F Barletta
Critical Care (London, England)|December 26, 2014
Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patientsJeffrey F Barletta, David A Sclar
The Annals of Pharmacotherapy|September 10, 2022
Challenges With Using a Weight-Based Approach to Bolus Fluid Dosing in Obese Critically Ill PatientsBrian L Erstad, Jeffrey F Barletta
Pageof 15

Showing results (11-20 of 145) with videos related to

Sort By:
Pageof 15
Pharmacoeconomics|November 26, 2013
Use of proton pump inhibitors for the provision of stress ulcer prophylaxis: clinical and economic consequencesJeffrey F Barletta, David A Sclar
Critical Care (London, England)|February 24, 2021
Drug dosing in the critically ill obese patient: a focus on medications for hemodynamic support and prophylaxisBrian L Erstad, Jeffrey F Barletta
The Journal of Emergency Medicine|July 29, 2022
Dosing Medications for Coagulopathy Reversal in Patients with Extreme ObesityJeffrey F Barletta, Brian L Erstad
The Annals of Pharmacotherapy|October 19, 2022
Dilemmas Related to Direct-Acting Oral Anticoagulant Administration in Patients With Extreme ObesityBrian L Erstad, Jeffrey F Barletta
World Journal of Surgery|April 1, 2014
Reducing the burden of postoperative ileus: evaluating and implementing an evidence-based strategyJeffrey F Barletta, Anthony J Senagore
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 29, 2022
Pharmacologic venous thromboembolism prophylaxis in obese trauma patientsBrian L Erstad, Jeffrey F Barletta
Journal of Critical Care|July 1, 2022
Pitfalls and pearls with drug dosing in the critically ill obese patient: 10 statements to guide ICU practitionersJeffrey F Barletta, Brian L Erstad
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 11, 2005
Albumin for fluid resuscitation: implications of the Saline versus Albumin Fluid EvaluationJohn W Devlin, Jeffrey F Barletta
Critical Care (London, England)|December 26, 2014
Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patientsJeffrey F Barletta, David A Sclar
The Annals of Pharmacotherapy|September 10, 2022
Challenges With Using a Weight-Based Approach to Bolus Fluid Dosing in Obese Critically Ill PatientsBrian L Erstad, Jeffrey F Barletta
Pageof 15